Monday, January 10, 2022 Daily Archives

ChargePoint enters liquid and fluid space with Terracon buy

by

ChargePoint Technology has acquired Terracon Corporation, a single-use product and accessory manufacturer used in the biopharma and life science sector. The deal sees powder transfer firm ChargePoint pay an undisclosed fee for Terracon, a company that designs, develops, and produces single-use products and accessories that can be used for transferring, mixing, and storing liquids and fluids. According to ChargePoint, the acquisition “brings us into the liquid and fluids handling space, which crosses over from a processing perspective with our AseptiSafe…

January 10, 2022

Amgen: Not treating biosimilars as ‘stepchild’ is key to success

by

Amgen says using the same development expertise and manufacturing capabilities for both its biosimilar and novel biologic programs sets it apart in the industry. Pharma firm Amgen is one of a handful of firms that has successfully invested in both innovator products and biosimilars – biologics that are very similar to reference biologics and for which there are no clinically meaningful differences in terms of safety, purity, and potency. With expected 2021 biosimilar revenues set to reach $2 billion, CEO…

January 10, 2022

British American Tobacco launches plant-based biotech KBio

by

The UK-headquartered biotech will combine British American Tobacco’s plant-based technology capabilities with subsidiary Kentucky BioProcessing. In 2020, Kentucky BioProcessing (KBP), the wholly owned subsidiary of the Big Tobacco firm British American Tobacco (BAT), entered the race to develop a COVID-19 vaccine. Development of the candidate is ongoing, but the program, will now fall under the arm of KBio Holdings Limited (KBio), a newly launched biotech incorporating the two entities. “It’s a new company, which essentially incorporates KBP activities and aims…

January 10, 2022